Knockdown of EBV-encoded CircRNA CircRPMS1 Suppresses Nasopharyngeal Carcinoma Cell Proliferation and Metastasis Through Sponging Multiple MiRNAs

Overview

Journal Cancer Manag Res

Publisher Dove Medical Press

Specialty Oncology

Date 2019 Nov 8

PMID 31695488

Citations 51

Authors

Qianwen Liu

Mingxia Shuai

Yong Xia

Affiliations

Soon will be listed here.

Abstract

Background: Epstein-Barr virus (EBV)-produced non-coding RNAs, including circular RNA (circRNA), regulate host cell gene expression and play important roles in development of nasopharyngeal carcinoma (NPC). EBV-encoded circRNA circRPMS1 consists of the head-to-tail splicing of exons 2-4 from the gene. Its roles and mechanism on NPC remain unknown.

Purpose: In this study, we investigated the biological functions and molecular mechanisms of circRPMS1 in tumor proliferation, apoptosis, invasion, metastasis and as a potential biomarker for NPC diagnosis and prognosis.

Patients And Methods: NPC tissues and the adjacent tissues were collected. Cell proliferation assay, cell apoptosis assay, cell invasion assay, luciferase reporter assay, RNA immunoprecipitation and tumor xenograft in nude mice were performed to analyze the circRPMS1 functions.

Results: We found that EBV-encoded circRPMS1 was increased in metastatic NPC and was associated with short survival time. Knockdown of circRPMS1 inhibited cell proliferation, induced apoptosis and repressed cell invasion in EBV-positive NPC cells. Further mechanism investigation revealed that circRPMS1-meadiated NPC oncogenesis through sponging multiple miRNA and promoting epithelial-mesenchymal transition (EMT). The inhibitors of miR-203, miR-31 and miR-451 could reverse the effects of circRPMS1 knockdown on NPC cells.

Conclusion: The findings indicate circRPMS1 as a potential therapeutic target for EBV-associated NPC. Our findings provide important understanding for the further elucidation on the therapeutic use of circRNA in NPC.

Citing Articles

Circular RNA circCLASP2 promotes nasopharyngeal carcinoma progression through binding to DHX9 to enhance PCMT1 translation.

Peng M, Zhang S, Wu P, Hou X, Wang D, Ge J Mol Cancer. 2025; 24(1):67.

PMID: 40050914 PMC: 11884054. DOI: 10.1186/s12943-025-02272-3.

Noncanonical circRNA biogenesis driven by alpha and gamma herpesviruses.

Dremel S, Koparde V, Arbuckle J, Hogan C, Kristie T, Krug L EMBO J. 2025; .

PMID: 40033018 DOI: 10.1038/s44318-025-00398-0.

Viral circular RNA-encoded protein, ceVP28, divulges an antiviral response in invertebrates.

Limkul S, Phiwthong T, Wanvimonsuk S, Seabkongseng T, Aunkam P, Jaree P Proc Natl Acad Sci U S A. 2025; 122(8):e2321707122.

PMID: 39964719 PMC: 11874341. DOI: 10.1073/pnas.2321707122.

Circular RNAs in the pathogenesis of SARS-CoV-2: potential diagnostic biomarkers and therapeutic targets.

Wu J, Li L, Xu W, Xia X, Wu Y Funct Integr Genomics. 2025; 25(1):4.

PMID: 39745517 DOI: 10.1007/s10142-024-01509-6.

Research progress on the role and mechanism of circular RNA in drug resistance of head and neck squamous cell carcinoma.

Zeng H, Ge J, Meng Y, Wang Q, Yang M, Zeng Z Cancer Drug Resist. 2024; 7:31.

PMID: 39403605 PMC: 11472580. DOI: 10.20517/cdr.2024.57.

References

Li H, Liu S, Hu J, Luo X, Li N, Bode A . Epstein-Barr virus lytic reactivation regulation and its pathogenic role in carcinogenesis. Int J Biol Sci. 2016; 12(11):1309-1318. PMC: 5118777. DOI: 10.7150/ijbs.16564. View

Khalil A, Guttman M, Huarte M, Garber M, Raj A, Rivea Morales D . Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci U S A. 2009; 106(28):11667-72. PMC: 2704857. DOI: 10.1073/pnas.0904715106. View

Chen L, Zhou H, Guan Z . CircRNA_000543 knockdown sensitizes nasopharyngeal carcinoma to irradiation by targeting miR-9/platelet-derived growth factor receptor B axis. Biochem Biophys Res Commun. 2019; 512(4):786-792. DOI: 10.1016/j.bbrc.2019.03.126. View

Zuo L, Yue W, Du S, Xin S, Zhang J, Liu L . An update: Epstein-Barr virus and immune evasion via microRNA regulation. Virol Sin. 2017; 32(3):175-187. PMC: 6702289. DOI: 10.1007/s12250-017-3996-5. View

Zhao C, Zhu W, Ba Z, Xu H, Liu W, Zhu B . The regulatory network of nasopharyngeal carcinoma metastasis with a focus on EBV, lncRNAs and miRNAs. Am J Cancer Res. 2018; 8(11):2185-2209. PMC: 6291648. View

Huang J, Chen J, Gong L, Bi Y, Liang J, Zhou L . Identification of virus-encoded circular RNA. Virology. 2019; 529:144-151. DOI: 10.1016/j.virol.2019.01.014. View

Zheng X, Wang J, Wei L, Peng Q, Gao Y, Fu Y . Epstein-Barr Virus MicroRNA miR-BART5-3p Inhibits p53 Expression. J Virol. 2018; 92(23). PMC: 6232473. DOI: 10.1128/JVI.01022-18. View

Lin C, Zong J, Lin W, Wang M, Xu Y, Zhou R . EBV-miR-BART8-3p induces epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma cells through activating NF-κB and Erk1/2 pathways. J Exp Clin Cancer Res. 2018; 37(1):283. PMC: 6257964. DOI: 10.1186/s13046-018-0953-6. View

Hui K, Yiu S, Tam K, Chiang A . Viral-Targeted Strategies Against EBV-Associated Lymphoproliferative Diseases. Front Oncol. 2019; 9:81. PMC: 6400835. DOI: 10.3389/fonc.2019.00081. View

10.

Wang M, Yu F, Wu W, Wang Y, Ding H, Qian L . Epstein-Barr virus-encoded microRNAs as regulators in host immune responses. Int J Biol Sci. 2018; 14(5):565-576. PMC: 5968849. DOI: 10.7150/ijbs.24562. View

11.

Hu H, Xu Z, Li C, Xu C, Lei Z, Zhang H . MiR-145 and miR-203 represses TGF-β-induced epithelial-mesenchymal transition and invasion by inhibiting SMAD3 in non-small cell lung cancer cells. Lung Cancer. 2016; 97:87-94. DOI: 10.1016/j.lungcan.2016.04.017. View

12.

Wang Y, Guo Z, Shu Y, Zhou H, Wang H, Zhang W . BART miRNAs: an unimaginable force in the development of nasopharyngeal carcinoma. Eur J Cancer Prev. 2016; 26(2):144-150. PMC: 5321115. DOI: 10.1097/CEJ.0000000000000221. View

13.

Gao W, Wong T, Lv K, Zhang M, Tsang R, Yu-Wai Chan J . Detection of Epstein-Barr virus (EBV)-encoded microRNAs in plasma of patients with nasopharyngeal carcinoma. Head Neck. 2018; 41(3):780-792. DOI: 10.1002/hed.25544. View

14.

Lyu X, Wang J, Guo X, Wu G, Jiao Y, Faleti O . EBV-miR-BART1-5P activates AMPK/mTOR/HIF1 pathway via a PTEN independent manner to promote glycolysis and angiogenesis in nasopharyngeal carcinoma. PLoS Pathog. 2018; 14(12):e1007484. PMC: 6312352. DOI: 10.1371/journal.ppat.1007484. View

15.

Li H, Hu J, Luo X, Bode A, Dong Z, Cao Y . Therapies based on targeting Epstein-Barr virus lytic replication for EBV-associated malignancies. Cancer Sci. 2018; 109(7):2101-2108. PMC: 6029825. DOI: 10.1111/cas.13634. View

16.

He B, Li W, Wu Y, Wei F, Gong Z, Bo H . Epstein-Barr virus-encoded miR-BART6-3p inhibits cancer cell metastasis and invasion by targeting long non-coding RNA LOC553103. Cell Death Dis. 2016; 7(9):e2353. PMC: 5059857. DOI: 10.1038/cddis.2016.253. View

17.

Imai S, Nishikawa J, Takada K . Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells. J Virol. 1998; 72(5):4371-8. PMC: 109667. DOI: 10.1128/JVI.72.5.4371-4378.1998. View

18.

Toptan T, Abere B, Nalesnik M, Swerdlow S, Ranganathan S, Lee N . Circular DNA tumor viruses make circular RNAs. Proc Natl Acad Sci U S A. 2018; 115(37):E8737-E8745. PMC: 6140489. DOI: 10.1073/pnas.1811728115. View

19.

Cheung C, Chung G, Lun S, To K, Choy K, Lau K . miR-31 is consistently inactivated in EBV-associated nasopharyngeal carcinoma and contributes to its tumorigenesis. Mol Cancer. 2014; 13:184. PMC: 4127521. DOI: 10.1186/1476-4598-13-184. View

20.

Fan C, Tang Y, Wang J, Xiong F, Guo C, Wang Y . The emerging role of Epstein-Barr virus encoded microRNAs in nasopharyngeal carcinoma. J Cancer. 2018; 9(16):2852-2864. PMC: 6096363. DOI: 10.7150/jca.25460. View